Skip to main content
Log in

Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Although tumefactive multiple sclerosis is a well recognized variant of multiple sclerosis, prognostic uncertainty still exists about long term prognosis. The aim of this study was to estimate the occurrence and long term outcome of tumefactive demyelinating lesions (TDLs) in a cohort of multiple sclerosis patients. We reviewed brain MRI of 443 patients referred to our MS clinic. All patients meeting the McDonald criteria for multiple sclerosis and showing at least one TDL were included. Kaplan–Meier estimates of disease-free survival in patient cohort were compared with control group without TDLs using a log-rank test. Seven cases with TDLs were identified (occurrence 1.58 %). Tumefactive demyelinating lesion recurrence was 16.6 %. Cumulative proportion of patients free from clinical relapse and from new T2 lesions was lower in the control group although not reaching statistical significance (30 vs 50 %; P = 0.666 and 21.7 vs 33.3 %; P = 0.761, respectively). Disability progression analysis showed a not significant trend towards lower probability of remaining progression free for TDL patients (50 vs 61 %; P = 0.295). Occurrence of tumefactive demyelinating lesions in our cohort was higher than those reported in other studies. Overall, TDLs were not predictive of poor outcome in terms of disability progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annal Neurol 69:292–302

    Article  PubMed  PubMed Central  Google Scholar 

  2. Charil A, Yousry TA, Rovaris M et al (2006) MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”. Lancet Neurol 5:841–852

    Article  PubMed  Google Scholar 

  3. Marsecano C, Perri M, Michelini G et al (2015) Vascular malformation mimicking multiple sclerosis active plaque: usefulness of susceptibility weighted imaging (SWI) to perform correct diagnosis. Neuroradiol J 28:488–492

    Article  PubMed  Google Scholar 

  4. Ciccarelli O, Miller DH (2002) Magnetic resonance imaging in multiple sclerosis. Pract Neurol 2:103–112

    Article  Google Scholar 

  5. Hardy TA, Chataway J (2013) Tumefactive demyelination: an approach to diagnosis and management. JNNP 0:1–7

    Google Scholar 

  6. De Medeiros FC, De Albuquerque LAF, Pittella JEH et al (2014) Open-ring enhancement in pseudotumoral multiple sclerosis: important radiological aspect. Case Rep Neurol Med 2014:951690

    PubMed  PubMed Central  Google Scholar 

  7. Ernst T, Chang L, Walot I et al (1998) Physiologic MRI of a tumefactive multiple sclerosis lesion. Neurology 51:1486–1488

    Article  CAS  PubMed  Google Scholar 

  8. Selkirk SM, Shi J (2005) Relapsing-remitting tumefactive multiple sclerosis. Mult Scler 11:731–734

    Article  PubMed  Google Scholar 

  9. Law M, Meltzer D, Cha S (2002) Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion. Neuroradiology 44:986–989

    Article  CAS  PubMed  Google Scholar 

  10. Tsui EYK, Leung WH, Chan JH et al (2002) Tumefactive demyelinating lesions by combined perfusion-weighted and diffusion weighted imaging. Comput Med Imaging Graph 26:343–346

    Article  CAS  PubMed  Google Scholar 

  11. Findling O, Sellner J, Ozdoba C et al (2007) Tumefactive lesion in multiple sclerosis. Acta Neurol Belg 107:134

    PubMed  Google Scholar 

  12. Kaeser MA, Scali F, Lanzisera FP et al (2011) Tumefactive multiple sclerosis: an uncommon diagnostic challenge. J Chiropr Med 10:29–35

    Article  PubMed  PubMed Central  Google Scholar 

  13. Khoshyomn S, Braff S, Penar P (2002) Tumefactive multiple sclerosis plaque. JNNP 73:85

    CAS  Google Scholar 

  14. Malhotra HS, Jain KK, Agarwal A et al (2009) Characterization of tumefactive demyelinating lesions using MR imaging and in vivo proton MR spectroscopy. Mult Scler 15:193–203

    Article  CAS  PubMed  Google Scholar 

  15. Saini J, Chatterjee S, Thomas B et al (2011) Conventional and advanced magnetic resonance imaging in tumefactive demyelination. Acta Radiol 52:1159–1168

    Article  PubMed  Google Scholar 

  16. Lucchinetti CF, Gavrilova RH, Metz I et al (2008) Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain 131:1759–1775

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Poser CM, Paty DW, Scheinberg L et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231

    Article  CAS  PubMed  Google Scholar 

  18. Kuan YC, Wang KC, Yuan WH et al (2013) Tumefactive multiple sclerosis in Taiwan. PLoS One 8:e69919

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Kiriyama T, Kataoka H, Taoka T et al (2011) Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm. J Neuroimaging 21(2):e69–e77

    Article  PubMed  Google Scholar 

  20. Totaro R, Di Carmine C, Carolei A (2014) Tumefactive demyelinating lesions in patients with relapsing remitting multiple sclerosis treated with Fingolimod. J Neurol Neurophysiol S12:006. doi:10.4172/2155-9562.S12-006

    Google Scholar 

  21. Kira J, Kanai T, Nishimura Y et al (1996) Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 40:569–574

    Article  CAS  PubMed  Google Scholar 

  22. Paty DW, Oger JJ, Kastrukoff LF et al (1988) MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38:180–185

    Article  CAS  PubMed  Google Scholar 

  23. Hunter S, Ballinger W, Rubin J (1987) Multiple sclerosis mimicking primary brain tumor. Arch Pathol Lab Med 111:464–468

    CAS  PubMed  Google Scholar 

  24. Annesley-Williams D, Farrell MA, Staunton H et al (2000) Acute demyelination, neuropathological diagnosis, and clinical evolution. J Neuropathol Exp Neurol 59:477–489

    Article  CAS  PubMed  Google Scholar 

  25. Altintas A, Petek B, Isik N et al (2012) Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study. Mult Scler 18:1448–1453

    Article  CAS  PubMed  Google Scholar 

  26. Beniac DR, Wood DD, Palaniyar N et al (1999) Marburg’s variant of multiple sclerosis correlates with a less compact structure of myelin basic protein. Mol Cell Biol Res Commun 1:48–51

    Article  CAS  PubMed  Google Scholar 

  27. Wood DD, Bilbao JM, O’Connors P et al (1996) Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein. Ann Neurol 40:18–24

    Article  CAS  PubMed  Google Scholar 

  28. Kepes J (1993) Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis: a study of 31 patients. Ann Neurol 33:18–27

    Article  CAS  PubMed  Google Scholar 

  29. Hayashi T, Kumabe T, Jokura H et al (2003) Inflammatory demyelinating disease mimicking malignant glioma. J Nucl Med 44:565–569

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rocco Totaro.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Totaro, R., Di Carmine, C., Splendiani, A. et al. Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis. Neurol Sci 37, 1113–1117 (2016). https://doi.org/10.1007/s10072-016-2558-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-016-2558-1

Keywords

Navigation